XM does not provide services to residents of the United States of America.
S
S

SEB

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

SEB Confirms 2024 Outlook

BRIEF-SEB Confirms 2024 Outlook Oct 24 (Reuters) - SEB SA SEBF.PA : THIRD-QUARTER SALES: EUR 1,985M, +4.0% LFLAND +3.4% REPORTED OUTLOOK FOR 2024 CONFIRMED NINE-MONTH OPERATING RESULT FROM ACTIVITY: EUR 444M, +14% Source text for Eikon: ID:nBw4Yt7rYa Further company coverage: SEBF.PA (Gdansk Newsroom)
S

Bodycote, Natwest Group, TAG Immobilien

EUROPE RESEARCH ROUNDUP-Bodycote, Natwest Group, TAG Immobilien Oct 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bodycote, Natwest Group and TAG Immobilien, on Tuesday. HIGHLIGHTS * Bodycote Plc BOY.L : RBC raises to outperform from sector perform * Delivery Hero SE DHER.DE : Citigroup cuts to neutral from buy * Natwest Group Plc NWG.L : Jefferies raises to buy from underperform * Paragon Banking PAGPA.L : Jefferies cuts to h
A
B
B
B
C
E
G
G
J
L
L
M
R
S
Z
A
B
I
N

Ivory Coast issues 106 cocoa export licences for 2024/25 season

Ivory Coast issues 106 cocoa export licences for 2024/25 season ABIDJAN, Oct 2 (Reuters) - Ivory Coast, the world's top cocoa producer, has granted cocoa export licences to 106 companies and cooperatives for the 2024/25 season, up from 92 last season , according to a document from the Coffee and Cocoa Council (CCC) seen by Reuters on Wednesday. They include the major traders and chocolate makers such as Olam OLAG.SI , CEMOI, Barry Callebaut BARN.S , Touton, Sucden, Nestle NESN.S and Cargill.
N
S

Exane starts coverage on appliance makers SEB and De Longhi

BUZZ-Exane starts coverage on appliance makers SEB and De Longhi ** Exane BNP Paribas says the global small domestic appliances (SDA) market is normalising and expects emerging consumption trends, new products to support demand ** Brokerage initiates SEB SEBF.PA at "outperform" and De Longhi DLG.MI at "neutral" citing their expansion in the profess
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.